CN Patent

CN1330311C — 3，4’，5－三羟基茋－3－β－D－葡萄糖甙在抗心肌缺血药物制备中的用途

Assigned to Shenzhen Neptunus Pharmaceutical Co Ltd · Expires 2007-08-08 · 19y expired

What this patent protects

本发明涉及化合物3，4’，5-三羟基茋-3-β-D-葡萄糖甙在药物制备中的新用途，特别是该化合物作为活性成分在治疗和/或预防缺血性心脏病的药用组合物中的用途，该药用组合物通过静脉注射或口服给药缺血性心肌及心功能损伤有显著的治疗或预防作用。

USPTO Abstract

本发明涉及化合物3，4’，5-三羟基茋-3-β-D-葡萄糖甙在药物制备中的新用途，特别是该化合物作为活性成分在治疗和/或预防缺血性心脏病的药用组合物中的用途，该药用组合物通过静脉注射或口服给药缺血性心肌及心功能损伤有显著的治疗或预防作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN1330311C
Jurisdiction
CN
Classification
—
Expires
2007-08-08
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Neptunus Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.